Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) virus, is a global pandemic impacting 254 million people in …

COVID-19 is a highly transmissible disease caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), affects 226 countries and continents, and has resulted in> 6.2 …

The devastating effects of the coronavirus disease 2019 (COVID-19) pandemic have made
clear a global necessity for antiviral strategies. Most fatalities associated with infection from …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause
immunosuppression and cytokine storm, leading to lung damage and death. The clinical …

COVID-19 is renowned as a multi-organ disease having subacute and long-term effects with
a broad spectrum of clinical manifestations. The evolving scientific and clinical evidence …

As many parts of the world continue to fight the innumerable waves of COVID‐19 infection,
SARS‐CoV‐2 continues to sculpt its antigenic determinants to enhance its virulence and …

Background As the therapeutic regimens against the COVID-19 remain scarce, the
microRNAs (miRNAs) can be exploited to generate efficient therapeutic targets. The miRNAs …

COVID-19 infection triggered a global public health crisis during the 2020–2022 period, and
it is still evolving. This highly transmissible respiratory disease can cause mild symptoms up …

The highly transmittable and infectious COVID-19 remains a major threat worldwide, with the
elderly and comorbid individuals being the most vulnerable. While vaccines are currently …

miRNA-146a, a single-stranded, non-coding RNA molecule, has emerged as a valuable
diagnostic and prognostic biomarker for numerous pathological conditions. Its primary …